Therefore, the CD95L–CD95 system appears to activate NF-κB-dependent survival signaling in ccRCC cells, whereas c-FLIP blocks CD95L-induced apoptosis and dampens NF-κB activity. Here, FAS is linked to nonpapillary renal cell carcinoma.